Von Eschenbach Defends FDA Action On Plan B During Confirmation Hearing
This article was originally published in The Pink Sheet Daily
Executive Summary
Acting commissioner defers when asked if he would accept a recess appointment to the FDA commissioner post, which would expire with the end of the next congressional season.